Skip to main content
Top
Published in: Archives of Virology 11/2008

01-11-2008 | Original Article

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique

Authors: Celina Monteiro Abreu, Patrícia A. Brindeiro, Angélica N. Martins, Mônica B. Arruda, Emilio Bule, Sergio Stakteas, Amilcar Tanuri, Rodrigo de Moraes Brindeiro

Published in: Archives of Virology | Issue 11/2008

Login to get access

Abstract

This work evaluated HIV-1 subtypes from different geographic regions and phenotypic data from drug-naïve HIV-positive pregnant women from Mozambique. We analyzed 75 pol sequences from patients and the distribution of the subtypes in three regions of Mozambique and found that the majority of samples analyzed clustered with subtype C. In the northern region, multiple variants were found 5 (~18%) subtype A, 3 (~11%) subtype D and 2 (~7.1%) mosaics (A/C/D and C/D), whereas 18 (64.3%) isolates were subtype C, from a total of 28 samples. Already in the southern region, only one (5%) isolate of 20 samples was subtype D, and the other 19 (95%) isolates were subtype C. All 27 (100%) isolates from the central region grouped within clade C. No primary resistance mutations to IP, NNRTI or NRTI were found. There was no evidence of phenotypic resistance in any of the isolates tested, suggesting that neither the polymorphism in the protease, nor the one found at codon 215 of the RT gene caused an increase in phenotypic resistance. This finding suggests that HAART regimens indicated by WHO will probably be successful in Mozambique.
Literature
1.
go back to reference Hemelaar J, Gouws E, Ghys PD, Osmanov S (2006) Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 16:W13–W23CrossRef Hemelaar J, Gouws E, Ghys PD, Osmanov S (2006) Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 16:W13–W23CrossRef
2.
go back to reference Boletim epidemiológico do ministério da Saúde de Moçambique MISAU- Resultados da ronda serologica de 2004 Boletim epidemiológico do ministério da Saúde de Moçambique MISAU- Resultados da ronda serologica de 2004
3.
go back to reference Dumans AT, Soares MA, Pieniazek D, Kalish ML, De Vroey V, Hertogs K, Tanuri A (2002) Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naïve human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. Antimicrob Agents Chemother 46(9):3075–3079PubMedCrossRef Dumans AT, Soares MA, Pieniazek D, Kalish ML, De Vroey V, Hertogs K, Tanuri A (2002) Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naïve human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. Antimicrob Agents Chemother 46(9):3075–3079PubMedCrossRef
4.
go back to reference Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EL, Brigido E, Pires IL, Morgado MG, Dantas MC, Barreira D, Teixeira PR, Cassol S, Tanuri A, The Brazilian Network for Drug Resistance Surveillance. (2003) A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 17:11–21PubMedCrossRef Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EL, Brigido E, Pires IL, Morgado MG, Dantas MC, Barreira D, Teixeira PR, Cassol S, Tanuri A, The Brazilian Network for Drug Resistance Surveillance. (2003) A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 17:11–21PubMedCrossRef
5.
go back to reference Kumar S, Tamura K, Nei M (2004) MEGA 3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150–163PubMedCrossRef Kumar S, Tamura K, Nei M (2004) MEGA 3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150–163PubMedCrossRef
6.
go back to reference Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD (2008) Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med 16(1):62–68PubMed Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD (2008) Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med 16(1):62–68PubMed
7.
go back to reference Shafer RWA, Rhee SA, Pillay DB, Miller VC, Sandstrom PD, Schapiro JMA, Kuritzkes DRE, Bennett DF (2007) HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 21(2):215–223PubMedCrossRef Shafer RWA, Rhee SA, Pillay DB, Miller VC, Sandstrom PD, Schapiro JMA, Kuritzkes DRE, Bennett DF (2007) HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 21(2):215–223PubMedCrossRef
8.
go back to reference Hertogs K, De Bethune MP, Miller V, Ivens T, Schel P, Van Cauwenberge A, Van Den Eynde C, Van Gerwen V, Azijn H, Van Houtte M, Peeters F, Staszewski S, Conant M, Bloor S, Kemp S, Larder B, Pauwels R (1998) A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant Human Immunodeficiency Virus Type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 42:269–276PubMedCrossRef Hertogs K, De Bethune MP, Miller V, Ivens T, Schel P, Van Cauwenberge A, Van Den Eynde C, Van Gerwen V, Azijn H, Van Houtte M, Peeters F, Staszewski S, Conant M, Bloor S, Kemp S, Larder B, Pauwels R (1998) A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant Human Immunodeficiency Virus Type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 42:269–276PubMedCrossRef
9.
go back to reference Lahuerta M, Aparicio E, Bardaji A, Marco S, Marco S, Sacarlal J, Mandomando I, Alonso P, Martinez MA, Menendez C, Naniche D (2008) Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique. AIDS Res Hum Retroviruses 24(2):327–335PubMedCrossRef Lahuerta M, Aparicio E, Bardaji A, Marco S, Marco S, Sacarlal J, Mandomando I, Alonso P, Martinez MA, Menendez C, Naniche D (2008) Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique. AIDS Res Hum Retroviruses 24(2):327–335PubMedCrossRef
10.
go back to reference Parreira R, Piedade J, Domingues A, Lobão D, Santos M, Venenno T, Baptista JL, Mussa SA, Barreto AT, Baptista AJ, Esteves A (2006) Genetic characterization of human Immunodeficiency virus type 1 from Beira, Mozambique. Microbes Infect 2442–2451 Parreira R, Piedade J, Domingues A, Lobão D, Santos M, Venenno T, Baptista JL, Mussa SA, Barreto AT, Baptista AJ, Esteves A (2006) Genetic characterization of human Immunodeficiency virus type 1 from Beira, Mozambique. Microbes Infect 2442–2451
11.
go back to reference Gonzalez LM, Brindeiro RM, Aguiar RS, Pereira HS, Abreu CM, Soares MA, Tanuri A (2004) Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases. Antimicrob Agents Chemother 48(9):3552–3555PubMedCrossRef Gonzalez LM, Brindeiro RM, Aguiar RS, Pereira HS, Abreu CM, Soares MA, Tanuri A (2004) Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases. Antimicrob Agents Chemother 48(9):3552–3555PubMedCrossRef
12.
go back to reference Kantor R, Katzenstein D (2003) Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev 5:25–35PubMed Kantor R, Katzenstein D (2003) Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev 5:25–35PubMed
13.
go back to reference Velazquez-Campoy A, Todd MJ, Veja S, Freire E (2001) Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes. Proc Natl Acad Sci USA 98:6062–6067PubMedCrossRef Velazquez-Campoy A, Todd MJ, Veja S, Freire E (2001) Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes. Proc Natl Acad Sci USA 98:6062–6067PubMedCrossRef
Metadata
Title
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique
Authors
Celina Monteiro Abreu
Patrícia A. Brindeiro
Angélica N. Martins
Mônica B. Arruda
Emilio Bule
Sergio Stakteas
Amilcar Tanuri
Rodrigo de Moraes Brindeiro
Publication date
01-11-2008
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2008
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-008-0215-6

Other articles of this Issue 11/2008

Archives of Virology 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine